Correlation of serum triglyceride and its reduction by ω-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high- density and low-density lipoproteins

Atherosclerosis

Volumn 143, Issue 2, 1999, Pages 285-297

  Pownall, Henry J ^a   Brauchi, Danièle ^a   Kilinç, Cumhur ^a   Osmundsen, Karin ^b   Pao, Quein ^a   Payton Ross, Charlotte ^a   Gotto Jr , Antonio M ^a   Ballantyne, Christie M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Pronova Biocare   (Norway)

Author keywords

3 Fatty acids; High density lipoprotein structure; Lipid metabolism; Lipid transfer; Low density lipoprotein structure; Serum triglyceride

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; OMEGA 3 FATTY ACID; OMEGA AMINO ACID;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FATTY ACID OMEGA OXIDATION; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; LIPID COMPOSITION; LIPID METABOLISM; LIPID TRANSPORT; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; BIOLOGICAL TRANSPORT; DOUBLE-BLIND METHOD; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; HYPERLIPOPROTEINEMIA TYPE IV; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; REFERENCE VALUES; SOFTWARE; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 0032917836     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00301-3     Document Type: Article

References (65)

1. Austin M.A. Serum triglyceride and coronary heart disease. Arterioscler. Thromb. 11:1991;2-14.
2. Austin M.A., King M.C., Vranizan K.M., Krauss R.M. Atherogenic lipoprotein phenotype: a proposed genetic marker for coronary heart disease risk. Circulation. 82:1990;495-506.
3. Austin M.A., Brunzell J.D., Fitch W.L., Krauss R.M. Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia. Arterioscler. Thromb. 10:1990;520-530.
4. Tall A. Serum lipid transfer proteins. Annu. Rev. Biochem. 65:1995;235-257.
5. Lagrost L. Regulation of cholesterol ester transfer protein activity: review of in vitro and in vivo studies. Biochim. Biophys. Acta. 1215:1994;209-236.
6. Tall A.R. Serum cholesteryl ester transfer protein. J. Lipid Res. 34:1993;1255-1274.
7. McKeone B.J., Patsch J.R., Pownall H.J. Serum triglyceride levels determine low density lipoprotein composition, physical properties and catabolism. J. Clin. Invest. 91:1993;1926-1933.
8. Deckelbaum R.J., Granot E., Oschry Y., Rose L., Eisenberg S. Plasma triglyceride determines structure-composition in low and high density lipoproteins. Arteriosclerosis. 4:1984;225-231.
9. Tollefson J.H., Ravnik S., Albers J.J. Isolation and characterization of a phospholipid transfer protein (LTP-I) from human serum. J. Lipid Res. 29:1988;593-602.
10. Lagrost L., Athias A., Gambert P., Lallemant C. Comparative study of phospholipid transfer activities mediated by cholesteryl ester transfer protein and phospholipid transfer protein. J. Lipid Res. 35:1994;825-835.
11. Jauhiainen M., Metso J., Pahlman R., Blomqvist S., van Tol A., Ehnholm C. Human serum phospholipid transfer protein causes high density lipoprotein conversion. J. Biol. Chem. 268:1993;4032-4036.
12. Albers J.J., Wolfbauer G., Cheung M.C. et al. Functional expression of human and mouse serum phospholipid transfer protein: effect of recombinant and serum PLTP on HDL subspecies. Biochim. Biophys. Acta. 1258:1995;27-34.
13. Tu A.Y., Nishida H.I., Nishida T. High density lipoprotein conversion mediated by human serum phospholipid transfer protein. J. Biol. Chem. 268:1993;23098-23105.
14. Kahri J., Sane T., van Tol A., Taskinen M.R. Effect of gemfibrozil on the regulation of HDL subfractions in hypertriglyceridemic patients. J. Intern. Med. 238:1995;429-436.
15. Weintraub M.S., Eisenberg S., Breslow J.L. Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals: effects of treatment with cholestyramine and gemfibrozil. J. Clin. Invest. 79:1987;1110-1119.
16. Mann C.J., Yen F.T., Grant A.M., Bihain B.E. Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. J. Clin. Invest. 88:1991;2059-2066.
17. Bagdade J.D., Ritter M.C., Davidson M., Subbaiah P.V. Effect of marine lipids on cholesteryl ester transfer and lipoprotein composition in patients with hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 12:1992;1146-1152.
18. Nozaki S., Matsuzawa Y., Hirano K., Sakai N., Kubo M., Tarui S. Effects of purified eicosapentaenoic acid ethyl ester on serum lipoproteins in primary hypercholesterolemia. Int. J. Vitam. Nutr. Res. 62:1992;256-260.
19. Weintraub M.S., Zechner R., Brown A., Eisenberg S., Breslow J.L. Dietary polyunsaturated fat of the ω-6 and ω-3 series reduces postprandial lipoprotein levels. J. Clin. Invest. 82:1998;1884-1893.
20. Day J.R., Albers J.J., Lofton-Day C.E. et al. Complete cDNA encoding human phospholipid transfer protein from human endothelial cells. J. Biol. Chem. 269:1994;9388-9391.
21. Otto D.A., Baltzell J.K., Wooten J.T. Reduction in triacylglycerol levels by fish oil correlates with free fatty acid levels in ad libitum fed rats. Lipids. 27:1992;1013-1017.
22. Otto D.A., Tsai C.E., Baltzell J.K., Wooten J.T. Apparent inhibition of hepatic triacylglycerol secretion, independent of synthesis, in high-fat fish oil-fed rats: role for insulin. Biochim. Biophys. Acta. 1082:1991;37-48.
23. Mackness M.I., Bhatnagar D., Durrington P.N. et al. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia. Eur. J. Clin. Invest. 48:1994;859-865.
24. National Cholesterol Education Program. Second report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation 1994;89:1329-1445.
25. Harris W. Fish oils and lipoprotein metabolism in humans: a critical review. J. Lipid Res. 30:1989;785-808.
26. Kohlmeier M., Riesen W., Schlierf G. Metabolic changes in healthy men using fat-modified diets (I): disposition of serum cholesterol. Ann. Nutr. Metab. 32:1988;1-9.
27. Bonaa K.H., Bjerve K.S., Nordoy A. Docosahexaenoic and eicosapentaenoic acids in plasma phospholipids are divergently associated with high density lipoprotein in humans. Arterioscler. Thromb. 12:1992;675-681.
28. Jacobs D.R. Jr., Barrett-Connor E. Retest reliability of plasma cholesterol and triglycerides: the Lipid Research Clinics Prevalence Study. Am. J. Epidemiol. 116:1982;878-885.
29. Chambless L.E., McMahon R.P., Brown S.A., Patsch W.A., Heiss G., Shen Y.L. Short-term intra individual variability in lipoprotein measurements: the Atherosclerosis Risk in Communities (ARIC) Study. Am. J. Epidemiol. 136:1992;1069-1081.
30. Patel K.M., Morrisett J.D., Sparrow J.T. The conversion of phosphatidylethanolamine into phosphatidylcholine labeled in the choline group using methyl iodide, 18-crown-6 and potassium carbonate. Lipids. 14:1979;596-597.
31. Homan R., Grossman J.E., Pownall H.J. Differential effects of eicosapentaenoic acid and oleic acid on lipid synthesis and secretion by HepG2 cells. J. Lipid Res. 32:1991;231-241.
32. Pownall H.J., Massey J.B., Kusserow S.K., Gotto A.M. Jr. Kinetics of lipid-protein interactions: interactions of apolipoprotein A-I from human serum high density lipoproteins with phosphatidylcholines. Biochemistry. 17:1978;1183-1188.
33. Kelley J.L., Kruski A.W. Density gradient ultracentrifugation of serum lipoproteins in a swinging bucket rotor. Methods Enzymol. 128:1986;170-181.
34. Patsch J.R., Sailor S., Kostner G., Sandhofer F., Holasek A., Braunsteiner H. Separation of the main lipoprotein density classes from human serum by rate zonal ultracentrifugation. J. Lipid Res. 15:1974;356-366.
35. Kato H., Nakanishi T., Arai H., Nishida H.I., Nishida T. Purification, microheterogeneity, and stability of human lipid transfer protein. J. Biol. Chem. 264:1989;4082-4087.
36. Kinoshita M., Arai H., Fukasawa M. et al. Apolipoprotein enhances lipid exchange between lipoproteins mediated by cholesteryl ester transfer protein. J. Lipid Res. 34:1993;261-268.
37. Tu A., Nishida H.I., Nishida T. High density lipoprotein conversion mediated by human serum phospholipid transfer protein. J. Biol. Chem. 268:1993;23098-23105.
38. Weinberg R.B., Cook V.R., Jones J.B., Kussie P., Tall A.R. Interfacial properties of recombinant human cholesterol ester transfer protein. J. Biol. Chem. 269:1994;29588-29591.
39. McPherson R., Mann C.J., Tall A.R. et al. Plasma concentrations of cholesteryl ester transfer protein in hyperlipoproteinemia: relation to cholesteryl ester transfer protein activity and other lipoprotein variables. Arterioscler. Thromb. 11:1991;797-804.
40. Leaf A., Weber P.C. Cardiovascular effects of n-3 fatty acids. New Engl. J. Med. 318:1988;549-557.
41. Leaf A. Cardiovascular effects of fish oils: beyond the platelet. Circulation. 82:1990;624-628.
42. Morris M.C., Sacks F., Rosner B. Does fish oil lower blood pressure: a meta-analysis of controlled trials. Circulation. 88:1993;523-533.
43. Hokanson J.E., Austin M.A. Plasma triglyceride is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol: a meta-analysis of population-based prospective studies. J. Cardiovasc. Risk. 3:1996;213-219.
44. International Task Force. Prevention of coronary heart disease: scientific background and new clinical guidelines: recommendations of the European Atherosclerosis Society prepared by the International Task Force for Prevention of Coronary Heart Disease. Nutr Metab Cardiovasc Dis 1992;2:113-156.
45. Gotto AM, Jr, Assmann G, Carmena R, et al. The ILIB lipid handbook for clinical practice: blood lipids and coronary heart disease. International Lipid Information Bureau, Houston TX, USA.
46. Brunzell JD. Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The Metabolic and Molecular Bases of Inherited Disease. 7th ed., vol. 2. New York: McGraw-Hill, 1995:1913-1932.
47. Assmann G., Gotto A.M. Jr., Paoletti R. The hypertriglyceridemias: risk and management: introduction. Am. J. Cardiol. 68:1991;1-4.
48. Patsch J.R., Karlin J.V., Scott L.W., Gotto A.M. Jr. Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia. Proc. Natl. Acad. Sci. USA. 80:1983;1449-1453.
49. 3 by hepatic lipase. J. Clin. Invest. 74:1984;2017-2023.
50. Weintraub M.S., Zechner R., Brown A., Eisenberg S., Breslow J.L. Dietary polyunsaturated fats of the ω-6 and ω-3 series reduce postprandial lipoprotein levels. J. Clin. Invest. 82:1988;1884-1893.
51. Hunninghake D.B., Peters J.R. Effect of fibric acid derivatives on blood lipid and lipoprotein levels. Am. J. Med. 83:1987;44-49.
52. Manninen V., Elo M.O., Frick M.H. et al. Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. JAMA. 260:1988;641-651.
53. Manttari M., Poskinen P., Manninen V., Huttunen J.K., Frick M.H., Nikkila E.A. Effect of gemfibrozil on the concentration and composition of serum lipoproteins: a controlled study with special reference to initial triglyceride levels. Atherosclerosis. 81:1990;11-17.
54. Shepherd J. The action of nicotinic acid and its analogues on lipoprotein metabolism. Atheroscler. Rev. 22:1991;207-212.
55. Fielding C.J., Fielding P.E. Molecular physiology of reverse cholesterol transport. J. Lipid Res. 36:1995;211-228.
56. Surette M.E., Whelan J., Broughton K.S., Kinsella J.E. Evidence for mechanism of the hypotriglyceridemic effect of n-3 polyunsaturated fatty acids. Biochim. Biophys. Acta. 1126:1992;199-205.
57. Wang J., Yao Z., Fisher E.A. The effects of n-3 fatty acids on the secretion of carboxyl-terminally truncated forms of human apoprotein B. J. Biol. Chem. 269:1994;18514-18520.
58. Dixon J.L., Furukawa S., Ginsberg H.N. Oleate stimulates secretion of apoB-containing lipoproteins from HepG2 cells by inhibiting early intracellular degradation of apolipoprotein B. J. Biol. Chem. 266:1991;5080-5086.
59. Halminski M.A., Marsh J.B., Harrison E.H. Differential effects of fish oil, safflower oil and palm oil on fatty acid oxidation and glycerolipid synthesis. J. Nutr. 121:1991;1554-1561.
60. Rustan A.C., Christiansen E.N., Drevon C.A. Serum lipids, hepatic glycerolipid metabolism and peroxisomal fatty acid oxidation in rats fed ω-3 and ω-6 fatty acids. Biochem. J. 283:1992;333-339.
61. Aviram M., Lund-Katz S., Phillips M.C., Chait A. The influence of the triglyceride content of low density lipoprotein on the interaction of apolipoprotein B-100 with cells. J. Biol. Chem. 263:1988;16842-16848.
62. Suzukawa M., Abbey M., Howe P.R., Nestel P.J. Effects of fish oil fatty acids on low density lipoprotein size, oxidizability, and uptake by macrophages. J. Lipid Res. 36:1995;473-484.
63. Kleinman Y., Eisenberg S., Oschry Y., Gavish D., Stein O., Stein Y. Defective metabolism of hypertriglyceridemic low density lipoprotein in cultured human skin fibroblasts: normalization with bezafibrate therapy. J. Clin. Invest. 75:1985;1796-1803.
64. Glick J.M., Adelman S.J., Phillips M.C., Rothblat G.H. Cellular cholesteryl clearance: relationship to the physical state of cholesteryl ester inclusions. J. Biol. Chem. 258:1983;13425-13430.
65. Adelman S.J., Glick J.M., Phillips M.C., Rothblat G.H. Lipid composition and physical state effects on cellular cholesteryl ester clearance. J. Biol. Chem. 259:1984;13844-13850.